1-3 of 3
Donald Kohn, MD
Close
Sort by
Journal Articles

In Vivo Biosafety Model To Assess Risk of Adverse Events from Retroviral and Lentiviral Vectors.

Gerhard Bauer, Mo Dao, Ph.D., Scott Case, Ph.D., Todd Meyerrose, Ph.D., Louisa Wirthlin, Phillip Herrbrich, Ph.D., Ping Zhou, Ph.D., Xiuli Wang, Ph.D., Susie Csik, Jesusa Arevalo, Dianne Skelton, Jon Walker, Karen Pepper, Gay Crooks, MD, Donald Kohn, MD, Jan Nolta, Ph.D.
Journal: Blood
Blood (2007) 110 (11): 2595.
https://doi.org/10.1182/blood.V110.11.2595.2595
Published: 2007
Journal Articles

Comparative Results of Gene Therapy for Adenosine Deaminase Deficiency with or without PEG-ADA Withdrawal and Myelosuppressive Chemotherapy.

Robert Sokolic, MD, Greg Podsakoff, MD, Linda Muul, PhD, Barbara Engel, MD, Jayashree Jagadeesh, BS, Elizabeth Garabedian, RN, MSLS, Denise Carbonaro, Laura Tuschong, BS, Joanna Ireland, Michael Hershfield, MD, John Tisdale, MD, Cynthia Dunbar, MD, Alan Wayne, MD, Donald Kohn, MD, Fabio Candotti, MD
Journal: Blood
Blood (2007) 110 (11): 501.
https://doi.org/10.1182/blood.V110.11.501.501
Published: 2007
Journal Articles

Human Progenitor and Stem Cell Expansion through Selective, Reversible Cytokine Receptor Signaling.

Hisham Abdel-Azim, MD, Yuhua Zhu, Roger Hollis, PhD, Xuili Wang, PhD, Qian-Lin Hao, Lora Barsky, Donald Kohn, MD, Gay Crooks, MD
Journal: Blood
Blood (2005) 106 (11): 31.
https://doi.org/10.1182/blood.V106.11.31.31
Published: 2005